Public Health Emergency - Leading a Nation Prepared
There are no drugs or other therapeutics presently approved by the U.S. Food and Drug Administration (FDA) to prevent or treat COVID-19. However, ASPR is sponsoring the development of a number of therapeutic products that are being made available under either
FDA’s expanded access program and/or have been granted an
Emergency Use Authorization by FDA.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages